Björn Dahlbäck Selected Research

Björn Dahlbäck Research Topics

Disease

19	Thrombosis (Thrombus) 01/2021 - 05/2002
11	Activated Protein C Resistance (APC Resistance) 05/2016 - 05/2002
9	Neoplasms (Cancer) 01/2022 - 12/2002
9	Atherosclerosis 08/2015 - 06/2006
8	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018 - 12/2002
8	Hemorrhage 05/2016 - 04/2002
6	Inflammation (Inflammations) 01/2020 - 04/2008
5	Thrombophilia 01/2022 - 08/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2015 - 01/2009
3	Venous Thromboembolism 04/2018 - 03/2014
3	Coronary Disease (Coronary Heart Disease) 07/2016 - 09/2008
3	Sepsis (Septicemia) 01/2016 - 01/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 04/2011
2	Protein S Deficiency (Deficiency, Protein S) 03/2018 - 12/2002
2	Alzheimer Disease (Alzheimer's Disease) 06/2017 - 07/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 03/2009
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2009
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2012 - 01/2010
2	Abdominal Aortic Aneurysm 03/2010 - 01/2010
2	Carcinogenesis 01/2009 - 12/2006
2	Factor V Deficiency 08/2003 - 10/2002
1	Genetic Risk Score 01/2020
1	Heart Failure 01/2020
1	Leukopenia 01/2019
1	Albuminuria 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2018
1	Chronic Renal Insufficiency 02/2018
1	Hemophilia A (Haemophilia) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Asthma (Bronchial Asthma) 10/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Vascular Diseases (Vascular Disease) 08/2015
1	Amyloidosis 07/2012
1	Lupus Nephritis 04/2011
1	Nephritis 04/2011
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Diabetes Mellitus 11/2010

Drug/Important Bio-Agent (IBA)

17	Apolipoproteins MIBA 01/2020 - 06/2006
16	Protein CIBA 01/2022 - 02/2003
14	AnticoagulantsIBA 01/2022 - 12/2002
13	factor V LeidenIBA 01/2022 - 05/2002
11	Factor V (Coagulation Factor V)IBA 05/2016 - 10/2002
10	Protein SIBA 01/2022 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
6	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 07/2009
5	HDL LipoproteinsIBA 02/2018 - 06/2006
5	Messenger RNA (mRNA)IBA 01/2016 - 11/2005
5	ApolipoproteinsIBA 12/2012 - 06/2006
4	Prothrombin (Factor II)IBA 01/2022 - 07/2008
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2018 - 08/2015
4	CholesterolIBA 07/2016 - 01/2008
4	growth arrest-specific protein 6IBA 06/2011 - 01/2010
3	AntithrombinsIBA 01/2022 - 01/2020
3	HDL CholesterolIBA 02/2018 - 05/2010
3	oxidized low density lipoproteinIBA 03/2012 - 05/2010
2	EnzymesIBA 01/2020 - 01/2010
2	ImmunosorbentsIBA 01/2020 - 01/2010
2	Biological ProductsIBA 01/2020 - 01/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 11/2010
2	Triglycerides (Triacylglycerol)IBA 02/2018 - 01/2018
2	Axl Receptor Tyrosine KinaseIBA 10/2017 - 12/2002
2	Protein Isoforms (Isoforms)IBA 05/2016 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2010
2	LipidsIBA 01/2016 - 08/2009
2	Apolipoproteins E (ApoE)IBA 08/2015 - 05/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2012 - 05/2010
2	Thrombin FDA Link 07/2012 - 04/2002
2	Apolipoproteins AIBA 04/2010 - 03/2010
2	TensinsIBA 01/2010 - 01/2009
2	LigandsIBA 07/2009 - 12/2006
2	LDL Receptors (LDL Receptor)IBA 01/2008 - 06/2006
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2020
1	Liver X ReceptorsIBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	anti-dsDNA autoantibodyIBA 01/2019
1	AlbuminsIBA 02/2018
1	CytokinesIBA 02/2018
1	lipoprotein cholesterolIBA 06/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2015
1	methylallyl trisulfide (MATS)IBA 03/2014
1	LDL CholesterolIBA 12/2012
1	Apolipoproteins B (ApoB)IBA 12/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2012
1	polyethylene glycol polyethyleneimine nanogelIBA 07/2012
1	Peptides (Polypeptides)IBA 07/2012
1	Amyloid (Amyloid Fibrils)IBA 07/2012
1	thioflavin TIBA 07/2012
1	MannansIBA 07/2012
1	Complement C4b-Binding ProteinIBA 06/2011
1	Antinuclear AntibodiesIBA 04/2011
1	Fibric Acids (Fibrates)IBA 11/2010
1	Lipoproteins (Lipoprotein)IBA 05/2010

Therapy/Procedure

2	Therapeutics 01/2009 - 04/2003
1	Renal Dialysis (Hemodialysis) 07/2012